Saida Satoshi

Affiliation and department：

Research field (1)： Tumor biology

Research keywords (1)： Leukemia

Research theme for competitive and other funds (3)：

2020 - 2023 小児最未分化型急性骨髄性白血病の病態解析および特異的治療の基盤開発
2020 - 2023 Integrated analysis of mechanisms of genetic susceptibility to cancer and clonal evolution in pediatric cancer
2014 - 2016 Pathogenetic and therapeutic studies of myeloid leukemia with Down syndrome using xenograft model

Papers (55)：

Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, et al. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Advances. 2023
中澤陽, 田坂佳資, 加藤格, 窪田博仁, 川崎秀徳, 内原嘉仁, 赤澤嶺, 丹治正大, 小川絵里, 岡本竜弥, et al. 生後早期発症腫瘍と染色体検査を契機にBRCA2変異Fanconi貧血と診断した1例. 日本小児科学会雑誌. 2023. 127. 9. 1233-1233
Hirokazu Kobushi, Satoshi Saida, Katsutsugu Umeda, Atsushi Iwai, Kagehiro Kozuki, Hirohito Kubota, Kuniaki Tanaka, Satoshi Obu, Yoshinori Uchihara, Keiji Tasaka, et al. High-dose carboplatin-irinotecan-temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma. Pediatric blood & cancer. 2023. 70. 7. e30331
Yuki Shino, Katsutsugu Umeda, Yoshinori Uchihara, Kazuki Mitani, Keiji Tasaka, Hideto Ogata, Hirokazu Kobushi, Satoshi Saida, Itaru Kato, Takeshi Yoshida, et al. Successful sequential therapy with rituximab and daratumumab for refractory posttransplant immune thrombocytopenic purpura. Pediatric blood & cancer. 2023. e30472
Keiji Tasaka, Itaru Kato, Shunki Takeshita, Yu Yoshioka, Ayuko Usami, Yoshinori Uchihara, Ryo Akazawa, Tatsuya Kamitori, Satoshi Saida, Katsutsugu Umeda, et al. Second relapse of FLT3-ITD-positive acute myeloid leukemia after discontinuation of 3-year post-transplant maintenance therapy with gilteritinib. Pediatric blood & cancer. 2023. 70. 5. e30185

ｍore...

MISC (9)：

大部聡, 梅田雄嗣, 才田聡, 加藤格, 平松英文, 荒川芳輝, 宇藤恵, 溝脇尚志, 足立壮一, 滝田順子. 頭蓋内germinomaの診断における髄液中胎盤型アルカリフォスファターゼ(PLAP)の有用性. 日本小児血液・がん学会雑誌. 2021. 58. 4. 295-295
Megumi Uto, Katsutsugu Umeda, Yoshiki Arakawa, Keiichi Takehana, Tatsuya Kamitori, Atsushi Iwai, Itaru Kato, Satoshi Saida, Hidefumi Hiramatsu, Yohei Mineharu, et al. VOLUMETRIC-MODULATED ARC WHOLE-BRAIN RADIOTHERAPY FOR THE PREVENTION OF PERMANENT ALOPECIA IN PEDIATRIC PATIENTS. NEURO-ONCOLOGY. 2020. 22. 457-457
窪田博仁, 梅田雄嗣, 上月景弘, 田中邦昭, 大封智雄, 濱端隆行, 納富誠司郎, 才田聡, 平松英文, 荒川芳輝, et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or refractory CNS germ cell tumors. 日本小児血液・がん学会雑誌(Web). 2016. 53. 4
窪田博仁, 納富誠司郎, 才田聡, 渡邉健一郎, 大封智雄, 濱端隆行, 加藤格, 梅田雄嗣, 平松英文, 荒川芳輝, et al. 再発に対して放射線治療を積極的に施行した後頭蓋窩退形成性上衣腫の2例. 日本小児血液・がん学会雑誌(Web). 2015. 52. 2
上月景弘, 才田聡, 平松英文, 梅田雄嗣, 八木英哉, 平家俊男, 足立壯一. TKIで多様な副作用を呈したPh1 double positive ALLの一例(A case of severe complicating disease associated with tyrosine kinase inhibitor (TKI) in the treatment of Ph1 double positive ALL). 日本小児血液・がん学会雑誌. 2014. 51. 4. 303-303

ｍore...

Lectures and oral presentations (2)：

Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML
(60th American Society of Hematology Annual Meeting & Exposition 2018)
Evolution of Leukemia in Children with Down Syndrome
(The 6th JSH international Symposium 2015)

Awards (2)：

2018/12 - American Society of Hematology ASH abstract achievement award (Travel Award)
2014/12 - Japanese Society of Hematology The incentive award, Japanese Society of Hematology

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page